Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDZ and LIM domain protein 1 (PDLIM1) is a cytoplasmic protein that acts as an adapter/scaffold associated with the actin cytoskeleton, containing an N-terminal PDZ domain and a C-terminal LIM domain[3][2][1]. It organizes multi-protein complexes by linking actin and α-actinin to various signaling proteins and plays key roles in regulating stress fibers, cell polarity, and cell migration in fibroblasts[3][2][1]. Dysregulation or misexpression of PDLIM1 and related family members has been implicated in cancer progression, cardiovascular diseases, and defects in cell adhesion and migration[2][3]. PDLIM1 has also been suggested to modulate signal transduction by sequestering nuclear factors in the cytoplasm[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDZ and LIM domain protein 1 (PDLIM1).